Related references
Note: Only part of the references are listed.Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Hypermethylation of the 16q23.1 Tumor Suppressor Gene ADAMTS18 in Clear Cell Renal Cell Carcinoma
Ben Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
ADAMTS-18: A metalloproteinase with multiple functions
Jianlu Wei et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2014)
The Metalloprotease ADAMTS8 Displays Antitumor Properties through Antagonizing EGFR-MEK-ERK Signaling and Is Silenced in Carcinomas by CpG Methylation
Gigi C. G. Choi et al.
MOLECULAR CANCER RESEARCH (2014)
Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells
Tingxiu Xiang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer
W. Du et al.
ONCOGENE (2013)
DACT1, an antagonist to Wnt/beta-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer
Xuedong Yin et al.
BREAST CANCER RESEARCH (2013)
Cdc25A Regulates Matrix Metalloprotease 1 through Foxo1 and Mediates Metastasis of Breast Cancer Cells
Xiaoling Feng et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
PLCD1 is a functional tumor suppressor inducing G2/M arrest and frequently methylated in breast cancer
Tingxiu Xiang et al.
CANCER BIOLOGY & THERAPY (2010)
Epithelial-mesenchymal transition in cancer development and its clinical significance
Masaaki Iwatsuki et al.
CANCER SCIENCE (2010)
The Tumor Suppressor UCHL1 Forms a Complex with p53/MDM2/ARF to Promote p53 Signaling and Is Frequently Silenced in Nasopharyngeal Carcinoma
Lili Li et al.
CLINICAL CANCER RESEARCH (2010)
Requirement of the Akt/β-Catenin Pathway for Uterine Carcinosarcoma Genesis, Modulating E-Cadherin Expression Through the Transactivation of Slug
Makoto Saegusa et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Genetic Inactivation of ADAMTS15 Metalloprotease in Human Colorectal Cancer
Cristina G. Viloria et al.
CANCER RESEARCH (2009)
Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas
H. Jin et al.
ONCOGENE (2007)
Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition
S. Julien et al.
ONCOGENE (2007)
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation
J Ying et al.
ONCOGENE (2006)
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
SB Baylin et al.
NATURE REVIEWS CANCER (2006)
Epithelial-mesenchymal transition in development and cancer:: role of phosphatidylinositol 3′ kinase/AKT pathways
L Larue et al.
ONCOGENE (2005)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells
Q Tao et al.
HUMAN MOLECULAR GENETICS (2002)
Distinct roles of the IκB kinase α and β subunits in liberating nuclear factor κB (NFκB) from IκB and in phosphorylating the p65 subunit of NF-κB
N Sizemore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains
S Cal et al.
GENE (2002)
Share Paper
